Cellectar Biosciences (CLRB) Institutional Ownership $4.71 -0.07 (-1.46%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$4.84 +0.13 (+2.65%) As of 08/7/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cellectar Biosciences (NASDAQ:CLRB)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$80.61MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$14.59M Get CLRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Cellectar Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLRB Institutional Buying and Selling by Quarter Cellectar Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/12/2025 Simplex Trading LLC173,129$54K0.0%+331.3%0.376% 5/8/2025 Baader Bank Aktiengesellschaft172,940$55K0.0%N/A0.375% 5/8/2025XTX Topco Ltd104,323$33K0.0%+122.6%0.226% 4/23/2025 Sequoia Financial Advisors LLC203,260$64K0.0%+1,301.8%0.441% 2/17/2025Squarepoint Ops LLC520,240$156K0.0%N/A1.129% 2/17/2025Bank of America Corp DE206,783$62K0.0%+25.3%0.449% 2/13/2025ADAR1 Capital Management LLC585,261$175K0.0%-42.7%1.270% 2/12/2025JPMorgan Chase & Co.182,403$55K0.0%+687.3%0.396% 11/19/2024Barclays PLC120,497$258K0.0%-30.0%0.292% 11/16/2024Geode Capital Management LLC352,452$754K0.0%+3.3%0.869% Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Barclays PLC120,497$258K0.0%-30.0%0.297% 11/15/2024XTX Topco Ltd53,022$113K0.0%-16.2%0.131% 11/6/2024 Oppenheimer & Co. Inc.12,500$27K0.0%N/A0.031% 10/30/2024Rosalind Advisors Inc.3,671,550$7.86M4.9%+35.7%10.241% 10/22/2024 Sequoia Financial Advisors LLC23,800$51K0.0%N/A0.066% 8/20/2024Nantahala Capital Management LLC1,833,325$4.58M0.3%-2.1%5.114% 8/16/2024Coastal Bridge Advisors LLC11,000$28K0.0%-31.3%0.031% 8/12/2024XTX Topco Ltd63,304$158K0.0%+432.4%0.177% 8/7/2024 AIGH Capital Management LLC3,036,187$7.59M2.4%+8.2%8.469% 7/12/2024Rosalind Advisors Inc.2,705,616$6.76M5.0%+335.4%7.547% 5/10/2024Vanguard Group Inc.1,191,081$4.74M0.0%+146.7%3.322% 4/25/2024Rosalind Advisors Inc.621,478$2.47M2.3%-69.0%1.926% 2/14/2024ADAR1 Capital Management LLC1,378,082$3.82M1.4%N/A11.213% 2/12/2024 AIGH Capital Management LLC1,915,220$5.31M2.1%+182.7%15.584% 2/9/2024Worth Venture Partners LLC693,909$1.92M1.0%+148.6%5.646% 1/1/2024Vanguard Group Inc.175,884$464K0.0%+2.3%1.431% 11/15/2023Worth Venture Partners LLC279,123$737K0.4%-11.0%2.808% 11/15/2023Acuta Capital Partners LLC121,300$320K0.2%N/A1.220% 11/13/2023 AIGH Capital Management LLC677,511$1.79M0.8%-16.7%6.816% 7/21/2023 1900 Wealth Management LLC18,000$35K0.0%+50.0%0.185% 2/16/2023 AIGH Capital Management LLC931,888$1.59M0.5%+434.3%9.924% 11/16/2022Maven Securities LTD25,000$84K0.0%-93.8%0.266% 11/14/2022Worth Venture Partners LLC41,636$140K0.1%-90.9%0.444% 11/14/2022Maven Securities LTD25,000$84K0.0%-93.8%0.266% 11/3/2022ACT Capital Management LLC21,750$73K0.1%-90.0%0.356% 10/31/2022 1900 Wealth Management LLC12,000$40K0.0%N/A0.196% 5/12/2022 AIGH Capital Management LLC1,837,046$1.26M0.3%+104.9%3.007% 4/27/2022 1900 Wealth Management LLC120,000$83K0.0%+100.0%0.196% 2/14/2022Maven Securities LTD400,000$266K0.0%-60.4%0.655% 2/10/2022 AIGH Capital Management LLC896,590$596K0.2%N/A1.467% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here11/15/2021Franklin Resources Inc.142,400$132K0.0%N/A0.233% 11/12/2021Renaissance Technologies LLC447,074$414K0.0%-55.8%0.732% 11/5/2021Cozad Asset Management Inc.51,000$47K0.0%+64.5%0.083% 9/17/2021Virtu Financial LLC49,780$59K0.0%N/A0.081% 8/17/2021PVG Asset Management Corp193,510$230K0.7%+1,804.6%0.317% 8/16/2021Maven Securities LTD650,000$793K0.0%-27.8%1.064% 8/16/2021State Street Corp147,846$176K0.0%N/A0.242% 8/16/2021Sabby Management LLC426,561$508K0.1%+9.6%0.698% 8/13/2021Renaissance Technologies LLC1,011,268$1.20M0.0%+13.3%1.655% 8/13/2021QS Investors LLC142,400$170K0.0%N/A0.233% 8/13/2021Geode Capital Management LLC397,170$472K0.0%+62.5%0.650% 8/13/2021Vanguard Group Inc.1,874,584$2.23M0.0%+14.1%3.068% 8/5/2021 GSA Capital Partners LLP297,653$354K0.0%+90.0%0.564% 8/4/2021 Envestnet Asset Management Inc.104,385$124K0.0%+354.3%0.198% 8/2/2021Advisor Group Holdings Inc.23,827$28K0.0%+221.4%0.045% 8/1/2021 Sterneck Capital Management LLC30,000$34K0.0%N/A0.057% 7/29/2021Cozad Asset Management Inc.31,000$37K0.0%+181.8%0.059% 5/19/2021Squarepoint Ops LLC136,942$220K0.0%N/A0.260% 5/18/2021Millennium Management LLC246,485$397K0.0%+1,249.3%0.467% 5/14/2021Dimensional Fund Advisors LP21,265$34K0.0%-33.8%0.040% (Data available from 1/1/2016 forward) CLRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLRB shares? During the previous two years, 18 institutional investors and hedge funds held shares of Cellectar Biosciences. The most heavily invested institutionals were Rosalind Advisors Inc. ($7.86M), AIGH Capital Management LLC ($7.59M), Vanguard Group Inc. ($4.74M), Nantahala Capital Management LLC ($4.58M), Worth Venture Partners LLC ($1.92M), Geode Capital Management LLC ($754K), and Acuta Capital Partners LLC ($320K).Learn more on Cellectar Biosciences' institutional investors. What percentage of Cellectar Biosciences' stock is owned by institutional investors? 16.41% of Cellectar Biosciences' stock is owned by institutional investors. Learn more on CLRB's institutional investor holdings. Which institutional investors have been buying Cellectar Biosciences' stock? Of the 15 institutional investors that purchased Cellectar Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($3.05M), AIGH Capital Management LLC ($1.47M), ADAR1 Capital Management LLC ($1.38M), Vanguard Group Inc. ($712.10K), Squarepoint Ops LLC ($520.24K), Worth Venture Partners LLC ($414.79K), and Sequoia Financial Advisors LLC ($212.56K). How much institutional buying is happening at Cellectar Biosciences? Institutional investors have bought a total of 2,338,224 shares in the last 24 months. This purchase volume represents approximately $80.61M in transactions. Which of Cellectar Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Cellectar Biosciences stock in the last 24 months: ADAR1 Capital Management LLC ($436.90K), Barclays PLC ($103.40K), Nantahala Capital Management LLC ($40K), XTX Topco Ltd ($10.28K), and Coastal Bridge Advisors LLC ($5K). How much institutional selling is happening at Cellectar Biosciences? Institutional investors have sold a total of 595,582 shares in the last 24 months. This volume of shares sold represents approximately $14.59M in transactions. Related Companies KPTI Major Shareholders XLO Major Shareholders RANI Major Shareholders MRSN Major Shareholders AKTX Major Shareholders ESLA Major Shareholders SNYR Major Shareholders ITRM Major Shareholders DYAI Major Shareholders CLSD Major Shareholders This page (NASDAQ:CLRB) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
